POST-MARKETING COMMITMENTS: ENSURING SAFETY AND EFFICACY THROUGH OUTCOME DECISIONS AND RISK MANAGEMENT

We offer late-phase clinical study services with an aim to further evaluate the safety, effectiveness, and long-term risks and benefits of a product in a larger and more diverse patient population.

Our services help our clients play a crucial role in ensuring the safety and effectiveness of drugs and medical devices after they are approved for use and help them to provide valuable information to physicians, patients, and regulatory authorities.

Extending our integrated model and expert teams into late phase, ACE Research can conduct both interventional and non-interventional type studies including:

  • Phase lllb and IV randomized clinical trials
  • Observational epidemiologic studies
  • Expanded access programs
  • Post-authorization safety studies
  • Health Economics and Outcomes Research
  • Competitive marketing claims studies
  • Pharmacovigilance
  • Registries